Pertussis Vaccine Market Competitive Landscape 2024-2033 – Major Players and Strategies

Overview and Scope
The pertussis vaccine refers to a vaccine that protects against whooping cough (pertussis), which is a highly contagious respiratory disease caused by the bacterium Bordetella pertussis. It is designed to stimulate the immune system to produce protective antibodies against the pertussis bacterium, thus reducing the risk of infection and its associated symptoms.

Sizing and Forecast
The pertussis vaccine market size has grown steadily in recent years. It will grow from $5.26 billion in 2023 to $5.5 billion in 2024 at a compound annual growth rate (CAGR) of 4.4%. The growth in the historic period can be attributed to disease prevalence, immunization programs, pediatric vaccination, regulatory approvals.

The pertussis vaccine market size is expected to see steady growth in the next few years. It will grow to $6.33 billion in 2028 at a compound annual growth rate (CAGR) of 3.6%. The growth in the forecast period can be attributed to booster vaccination, maternal immunization, immunization for healthcare workers, global health initiatives. Major trends in the forecast period include personalized immunization schedules, combination vaccines, vaccine equity initiatives, digital health for immunization.

To access more details regarding this report, visit the link:
https://www.thebusinessresearchcompany.com/report/pertussis-vaccine-global-market-report

Segmentation & Regional Insights
The pertussis vaccine market covered in this report is segmented –
1) By Product Type: DTaP (Diphtheria, Tetanus and Acellular Pertussis) Vaccine; Tdap (Tetanus, Diphtheria and Pertussis) Vaccine
2) By Vaccine Type: Whole-Cell Vaccine; Acellular Vaccine
3) By Application: Children; Adults; Infants
4) By End-User: Vaccination Centers; Hospitals; Clinics

North America was the largest region in the pertussis vaccine market in 2023. The regions covered in pertussis vaccine market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Intrigued to explore the contents? Secure your hands-on sample copy of the report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13023&type=smp

Major Driver Impacting Market Growth
Rising childbirth rates are driving the growth of the pertussis vaccine market going forward. Childbirth is the term for the act of giving birth to a child. It is the culmination of pregnancy, during which the fetus develops in the mother’s uterus and marks the beginning of a new life outside the womb. The pertussis vaccine is primarily used for children because it helps protect them from whooping cough and other severe and potentially deadly diseases. For instance, in May 2022, according to the Center for Disease Control and Prevention (CDC), a US-based government organization, there were 3.66 million births in the US in 2021, compared to 3.61 million in 2020. Furthermore, in 2021, according to Statistics Canada, a Canada-based government agency, in Canada, births increased by 2% from 360,552 in 2020 to 367,684 in 2021. Therefore, the rising childbirth rates are driving the growth of the pertussis vaccine market.

Key Industry Players
Major players in the pertussis vaccine market are Pfizer Inc., Johnson And Johnson Pvt Ltd., Merck And Co. Inc., Novartis AG, GlaxoSmithKline PLC, AstraZeneca PLC, BioNTech SE, Moderna Inc., Sinovac Biotech Ltd., CSL Limited, Astellas Pharma US Inc., Sanofi Pasteur SA, Mitsubishi Tanabe Pharma America Inc., PT Kalbe Farma Tbk, CSL Seqirus, Walvax Biotechnology Co.Ltd., Biological E. Limited, Serum Institute of India, Bavarian Nordic AS, PT Bio Farma, Bharat Biotech International Limited, Takeda Pharmaceutical Company, Panacea Biotec Limited, Beijing Minhai Biotechnology Co. Ltd., Protein Sciences Corporation, Wuhan Institute of Biological Products, Changchun Changsheng Life Sciences, Changsheng Bio-Technology Co. Ltd., Gennova Biopharmaceuticals Ltd., Chiron Corporation.

The pertussis vaccine market report table of contents includes:
1. Executive Summary
2. Pertussis Vaccine Market Characteristics
3. Pertussis Vaccine Market Trends And Strategies
4. Pertussis Vaccine Market – Macro Economic Scenario
5. Global Pertussis Vaccine Market Size and Growth
….
30. Pertussis Vaccine Market Competitive Landscape And Company Profiles
31. Pertussis Vaccine Market Other Major And Innovative Companies
32. Global Pertussis Vaccine Market Competitive Benchmarking
33. Global Pertussis Vaccine Market Competitive Dashboard
34. Key Mergers And Acquisitions In The Pertussis Vaccine Market
35. Pertussis Vaccine Market Future Outlook and Potential Analysis
36. Appendix

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model